Sandro Conrad
Impact in
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment
- Oncology top 5%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
Papers in
-
- Carcinogens and Genotoxicity Assessment 7
- Oncology 4
- PARP inhibition in cancer therapy 3
- Cancer-related Molecular Pathways 1
- Co-authors
- Markus Löbrich (8 shared papers)Penny Ann Jeggo (4 shared papers)Atsushi Shibata (3 shared papers)Olivia Barton (3 shared papers)G. Taucher-Scholz (2 shared papers)Aaron A. Goodarzi (2 shared papers)Andreas Kakarougkas (2 shared papers)M. Ismail (2 shared papers)
- Journals
- Nucleic Acids Research (2 papers)The EMBO Journal (2 papers)Proceedings of the National Academy of Sciences (2 papers)The Journal of General Physiology (1 paper)Cell Cycle (1 paper)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Sandro Conrad
12 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 92
- Cancer Research 339
- Oncology 499
- Molecular Biology 1.3k
- Radiology, Nuclear Medicine and Imaging 213
- Pulmonary and Respiratory Medicine 248
Countries citing papers authored by Sandro Conrad
This map shows the geographic impact of Sandro Conrad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandro Conrad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandro Conrad more than expected).
Fields of papers citing papers by Sandro Conrad
This network shows the impact of papers produced by Sandro Conrad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandro Conrad. The network helps show where Sandro Conrad may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandro Conrad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 439 | |
| 2 | 2011 | 399 | |
| 3 | 2011 | 253 | |
| 4 | 2010 | 132 | |
| 5 | 2014 | 87 | |
| 6 | 1981 | 86 | |
| 7 | 2013 | 80 | |
| 8 | 2013 | 70 | |
| 9 | 2011 | 35 | |
| 10 | 2009 | 25 | |
| 11 | 2015 | 19 | |
| 12 | 1980 | 9 |
About Sandro Conrad
Sandro Conrad is a scholar working on Cancer Research, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Cellular and Molecular Neuroscience, having authored 12 papers that have together received 1.6k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (8 papers), Carcinogens and Genotoxicity Assessment (7 papers), Radiation Therapy and Dosimetry (4 papers), PARP inhibition in cancer therapy (3 papers), Effects of Radiation Exposure (2 papers), Photoreceptor and optogenetics research (2 papers), Cancer-related Molecular Pathways (1 paper) and Neurobiology and Insect Physiology Research (1 paper). The work is most often cited by research in Cancer Research (339 citations), Oncology (499 citations), Molecular Biology (1.3k citations), Radiology, Nuclear Medicine and Imaging (213 citations) and Pulmonary and Respiratory Medicine (248 citations). Sandro Conrad has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Markus Löbrich, Penny Ann Jeggo, Atsushi Shibata, Olivia Barton, G. Taucher-Scholz, Aaron A. Goodarzi, Andreas Kakarougkas, M. Ismail, Andrea Krempler and Marco Durante. Their work appears in journals such as Nucleic Acids Research, The EMBO Journal, Proceedings of the National Academy of Sciences, The Journal of General Physiology and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.